Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States.
Iterum Therapeutics stock last closed at $0.99, down 0.5% from the previous day, and has decreased 15.3% in one year. It has overperformed other stocks in the Biotechnology industry by 0.61 percentage points. Iterum Therapeutics stock is currently +22.65% from its 52-week low of $0.81, and -67.19% from its 52-week high of $3.02.
There are currently 40M ITRM shares outstanding. The market value of ITRM is $39.64M. In the last 24 hours, 459,000 ITRM shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ITRM stock.
In our opinion, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal information so you can buy ITRM today.
Now that you've finished signing up on the best stock trading app for beginners, you need to deposit funds:
Check out the walkthrough below if you need help transferring money into your investment account.
Once you have chosen the best place to buy Iterum Therapeutics stock, it's critical to research their stock before you buy, so you actually understand the risk as well as the opportunity.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on ITRM's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ITRM's intrinsic value.
You can access additional valuation analysis on ITRM's stock here.
Out of 1 sell side analysts who research ITRM, the consensus analyst rating on Iterum Therapeutics is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Iterum Therapeutics stock forecast page.
In the past 12 months, executives and large shareholders at ITRM have not bought or sold any shares.
Research more about who owns ITRM shares here.
No, Iterum Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main order types:
Hit the Open button and eToro will place your order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
Now that you own some ITRM shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track the latest developments regarding your ITRM stock.
To reiterate, here are the 6 steps for buying Iterum Therapeutics stock:
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Iterum Therapeutics, add ITRM to your watchlist below.